Plantago ovata seed

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Plantago ovata seed
Accession Number
DB14585
Type
Biotech
Groups
Approved, Experimental, Investigational
Description
Not Available
Synonyms
  • Blond psyllium
  • Blonde psyllium
  • Indian plantain seed
  • Indian psyllium
  • Ispaghul
  • Ispaghula
  • Ispaghula extract
  • Ispaghula husk
  • Ispaghula seed
  • Plantaginis ovatae semen
  • Plantaginis ovatae testa
  • Plantago brunnea seed
  • Plantago fastigiata seed
  • Plantago gooddingii seed
  • Plantago insularis seed
  • Plantago minima seed
  • Psyllium seed, blonde
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
MucilinPowder2.45 g/5gOralParadigm Pharmaceuticals Inc2018-07-302019-12-22Us
Mucilin SfPowder3.5 g/5gOralParadigm Pharmaceuticals Inc2018-07-302019-12-22Us
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Categories
UNII
K9NXW456E2
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Plantago ovata seed.
AclidiniumThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Aclidinium.
AgmatineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Agmatine.
AlcuroniumThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Alcuronium.
AlfentanilThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Plantago ovata seed is combined with Alloin.
AlphacetylmethadolThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Alphaprodine.
AmantadineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Plantago ovata seed.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
RxNav
1309942
ATC Codes
A06AC51 — Ispaghula, combinations

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2TerminatedTreatmentMetabolic Syndromes1
Not AvailableRecruitingTreatmentFecal Incontinence1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
PowderOral2.45 g/5g
PowderOral3.5 g/5g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on August 19, 2018 14:47 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates